Left behind on the path to 90-90-90: understanding and responding to HIV among displaced people.

HIV care continuum HIV prevention HIV treatment displaced people forced migration lower- and middle-income countries

Journal

Journal of the International AIDS Society
ISSN: 1758-2652
Titre abrégé: J Int AIDS Soc
Pays: Switzerland
ID NLM: 101478566

Informations de publication

Date de publication:
11 2022
Historique:
received: 10 05 2022
accepted: 20 10 2022
entrez: 10 11 2022
pubmed: 11 11 2022
medline: 15 11 2022
Statut: ppublish

Résumé

In 2021, the number of people affected by displacement worldwide reached the highest on record, with an estimated 30.5 million refugees and 4.6 million asylum seekers seeking safety across international borders and further 53.2 million people displaced within their countries of origin. Most forcibly displaced persons come from or relocate to lower- and middle-income countries (LMICs) and many of those countries have large HIV epidemics. In this commentary, we describe some of the challenges at the intersection of HIV and displacement vulnerabilities that cannot be easily addressed in resource-limited environments. HIV transmission and prevention and treatment efforts in the context of displacement are affected by myriad behavioural, social and structural factors across different stages of the displacement journey. For example, structural barriers faced by people experiencing displacement in relation to HIV prevention and care include funding constraints and legal framework deficiencies. Such barriers prevent all forced migrants, and particularly those whose sexual identities or practices are stigmatized against, access to prevention and care equal to local residents. Xenophobia, racism and other social factors, as well as individual risky behaviours facilitated by experiences of forced migration, also affect the progress towards 90-90-90 targets in displaced populations. Current evidence suggests increased HIV vulnerability in the period before displacement due to the effect of displacement drivers on medical supplies and infrastructure. During and after displacement, substantial barriers to HIV testing exist, though following resettlement in stable displacement context, HIV incidence and viral suppression are reported to be similar to those of local populations. Experiences of often-marginalized displaced populations are diverse and depend on the context of displacement, countries of origin and resettlement, and the nature of the crises that forced these populations to move. To address current gaps in responses to HIV in displacement contexts, research in LMIC, particularly in less stable resettlement settings, needs to be scaled up. Furthermore, displaced populations need to be specifically addressed in national AIDS strategies and HIV surveillance systems. Finally, innovative technologies, such as point-of-care viral load and CD4 testing, need to be developed and introduced in settings facing displacement.

Identifiants

pubmed: 36352546
doi: 10.1002/jia2.26031
pmc: PMC9646984
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e26031

Informations de copyright

© 2022 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.

Références

J Acquir Immune Defic Syndr. 2014 Dec 1;67(4):409-13
pubmed: 25162817
AIDS Res Hum Retroviruses. 2017 Nov;33(11):1149-1154
pubmed: 28540733
PLoS One. 2015 Sep 23;10(9):e0138511
pubmed: 26398658
JMIR Public Health Surveill. 2017 Jun 23;3(2):e41
pubmed: 28645888
BMC Res Notes. 2018 Jul 31;11(1):535
pubmed: 30064508
Sci Adv. 2018 Jun 20;4(6):eaaq0883
pubmed: 29938219
Confl Health. 2015 Feb 02;9(Suppl 1 Taking Stock of Reproductive Health in Humanitarian):S4
pubmed: 25798190
Soc Sci Med. 2014 Nov;120:387-95
pubmed: 25048975
PLoS One. 2016 May 13;11(5):e0155256
pubmed: 27175484
BMJ. 2019 Apr 1;365:l1083
pubmed: 30936067
AIDS Rev. 2013 Jan-Mar;15(1):15-24
pubmed: 23449225
Proc Natl Acad Sci U S A. 2016 Jul 5;113(27):7449-53
pubmed: 27325782
J Health Care Poor Underserved. 2015 May;26(2):505-18
pubmed: 25913347
Psychol Health Med. 2011 Oct;16(5):588-611
pubmed: 21745024
AIDS Care. 2013 Aug;25(8):998-1009
pubmed: 23305523
BMC Public Health. 2022 Jun 16;22(1):1203
pubmed: 35710413
J Int AIDS Soc. 2018 Jul;21 Suppl 4:e25115
pubmed: 30027668
BMC Public Health. 2018 Aug 8;18(1):987
pubmed: 30089475
Int J Equity Health. 2019 Aug 16;18(1):127
pubmed: 31420037
JMIR Mhealth Uhealth. 2018 Jan 17;6(1):e23
pubmed: 29343463
Emerg Themes Epidemiol. 2004 Oct 29;1(1):6
pubmed: 15679919
BMC Int Health Hum Rights. 2015 Apr 03;15:7
pubmed: 25884930
Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):1051-1056
pubmed: 29339468
BMC Public Health. 2015 Sep 03;15:848
pubmed: 26334626
PLoS One. 2014 Feb 28;9(2):e89786
pubmed: 24587034
J Int AIDS Soc. 2021 Mar;24(3):e25674
pubmed: 33713571
J Interpers Violence. 2022 May;37(9-10):NP7470-NP7501
pubmed: 33118459
Lancet. 2018 Dec 15;392(10164):2606-2654
pubmed: 30528486
Confl Health. 2016 Mar 09;10:3
pubmed: 26962327
AIDS. 2021 May 1;35(6):979-984
pubmed: 33470610
PLoS One. 2015 Nov 12;10(11):e0142343
pubmed: 26562434
PLoS One. 2016 Jul 13;11(7):e0159134
pubmed: 27411086
BMC Infect Dis. 2018 Jul 16;18(1):332
pubmed: 30012110
Confl Health. 2017 May 31;11:11
pubmed: 28572840
PLoS Curr. 2014 Mar 18;6:
pubmed: 24818066
BMJ Open. 2020 Nov 6;10(11):e040646
pubmed: 33158835
Soc Sci Med. 2014 Jan;100:38-45
pubmed: 24444837
PLoS Med. 2014 Jun 10;11(6):e1001643
pubmed: 24915050
Cochrane Database Syst Rev. 2020 Sep 4;9:CD013458
pubmed: 32885850
AIDS Behav. 2010 Dec;14(Suppl 2):222-38
pubmed: 20838871
Anthropol Med. 2020 Dec;27(4):363-379
pubmed: 31801356
Soc Sci Med. 2006 Apr;62(8):1931-42
pubmed: 16242227
Ann Glob Health. 2020 Jun 24;86(1):66
pubmed: 32607311
Confl Health. 2016 Jun 01;10:12
pubmed: 27252775
Glob Public Health. 2021 May;16(5):746-762
pubmed: 33275869
BMC Public Health. 2019 Dec 16;19(1):1683
pubmed: 31842822
Nature. 2016 Feb 11;530(7589):228-232
pubmed: 26840485
Med Confl Surviv. 2013 Jul-Sep;29(3):198-215
pubmed: 24133930
PLoS One. 2020 Sep 17;15(9):e0239187
pubmed: 32941533
AIDS Behav. 2016 Feb;20(2):243-61
pubmed: 25662963
J Sex Res. 2017 Sep;54(7):936-948
pubmed: 27715333
HIV AIDS (Auckl). 2014 Feb 26;6:19-38
pubmed: 24600250
AIDS. 2002 Nov 22;16(17):2245-52
pubmed: 12441795
AIDS Behav. 2021 Jun;25(6):1729-1736
pubmed: 33263892
BMC Health Serv Res. 2016 Aug 02;16(a):343
pubmed: 27484023
J Immigr Minor Health. 2014 Feb;16(1):165-76
pubmed: 23124632
J Public Health Policy. 2018 Nov;39(4):407-423
pubmed: 30177729
Trauma Violence Abuse. 2019 Dec;20(5):638-652
pubmed: 29333997
Reprod Health. 2020 Jun 22;17(1):99
pubmed: 32571350
BMC Med. 2020 Dec 3;18(1):381
pubmed: 33267890
Lancet HIV. 2020 Mar;7(3):e173-e183
pubmed: 31953184
Lancet. 2007 Jun 30;369(9580):2187-2195
pubmed: 17604801
J Clin Microbiol. 2019 Mar 28;57(4):
pubmed: 30700508
Lancet Glob Health. 2019 Apr;7(4):e420-e435
pubmed: 30852188
Lancet HIV. 2022 Jun;9(6):e438-e448
pubmed: 35576942
AIDS Behav. 2012 Aug;16(6):1605-21
pubmed: 22481273
BMC Public Health. 2020 Jun 30;20(1):1039
pubmed: 32605605
BMC Infect Dis. 2016 Oct 21;16(1):592
pubmed: 27769181
Annu Rev Public Health. 2015 Mar 18;36:375-92
pubmed: 25494053
AIDS Behav. 2014 Feb;18(2):323-34
pubmed: 23748862
Confl Health. 2018 Jun 1;12:20
pubmed: 29881448
AIDS Behav. 2016 Dec;20(Suppl 3):417-425
pubmed: 27448215
AIDS Behav. 2014 Dec;18(12):2302-13
pubmed: 24257897

Auteurs

Tetyana I Vasylyeva (TI)

Division of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, California, USA.

Danielle's Horyniak (D)

Public Health Discipline, Burnet Institute, Melbourne, Victoria, Australia.
School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

Ietza Bojorquez (I)

Department of Population Studies, El Colegio de la Frontera Norte, Tijuana, Mexico.

Minh Duc Pham (MD)

Public Health Discipline, Burnet Institute, Melbourne, Victoria, Australia.
School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH